Injectable Body Builder Abiraterone Acetate CAS 154229-19-3

Active Pharmaceuticals Ingredients Abiraterone CAS 154229-19-3 for Prostate Cancer Treatment
 
Quick Detail of Active Pharmaceutical Ingredients Abiraterone :
 
Product Name: Abiraterone
Synonyms:
abiraterone;17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-;Cb 7598;Cb-7598;Unii-G819A456D0;Abiraterone(CB-7598);(3S,8R,9S,10R,13S,14S)-10,13-diMethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;
 
CAS: 154229-19-3;
MF: C24H31NO;
MW: 349.51.
   
Description of Active Pharmaceutical Ingredients Abiraterone:
 
(1) Abiraterone is a new type of hormone therapy. It is also called abiraterone acetate. It is used to treat prostate cancer that has spread to other parts of the body. It may help some men to live longer. It can also help control symptoms. Clinical trials are also using abiraterone for earlier stages of prostate cancer and advanced breast cancer. Abiraterone is associated with a not uncommon rate of serum enzyme elevation during therapy, but has not been clearly linked to cases of clinically apparent liver injury with jaundice.
 
(2) Abiraterone is a steroidal compound with antiandrogen activity. it is a Cytochrome P450 17A1 Inhibitor. The mechanism of action of abiraterone is as a Cytochrome P450 17A1 Inhibitor, and Cytochrome P450 2D6 Inhibitor, and Cytochrome P450 2C8 Inhibitor that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis. Administration of this agent may suppress testosterone production by both the testes and the adrenals to castrate-range levels.
 
Medical Usage for Active Pharmaceutical Ingredients Abiraterone:
 
(1) Abiraterone, a steroidal cytochrome P 450 17alpha-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent pr ostate cancer.
 
(2) Currently, for patients of advanced prostate cancer, androgen deprivation therapy including drugs and surgery is generally the preferred method of including drugs and surgery in order to reduce the testicular androgen synthesis. However, this treatment can't suppress other parts of the body for yielding the male hormone.
(3) Abiraterone is a therapeutic agent for prostate cancer with the English name for Abiraterone. It is developed by researchers coming from the British Royal Marsden Hospital located in southwest (world-renowned cancer research treatment center). It is kind of drug which is able to repress any part of the body for androgen production. It can not only reduce the levels of the prostate-specific antigen (PSA) which represents the tumor activity, but also helps to shrink the tumor. It can also apply to cancer patients who have been subject to chemotherapy in the past, revealing treatment hope.
 
Technical Testing Sheet of  Active Pharmaceutical Ingredients Abiraterone:
 
COA:
   
How to Complete an Order
 
Active Pharmaceuticals Ingredients Abiraterone CAS 154229-19-3 for Prostate Cancer Treatment
 
Quick Detail of Active Pharmaceutical Ingredients Abiraterone :
 
Product Name: Abiraterone
Synonyms:
abiraterone;17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-;Cb 7598;Cb-7598;Unii-G819A456D0;Abiraterone(CB-7598);(3S,8R,9S,10R,13S,14S)-10,13-diMethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;
 
CAS: 154229-19-3;
MF: C24H31NO;
MW: 349.51.
   
Description of Active Pharmaceutical Ingredients Abiraterone:
 
(1) Abiraterone is a new type of hormone therapy. It is also called abiraterone acetate. It is used to treat prostate cancer that has spread to other parts of the body. It may help some men to live longer. It can also help control symptoms. Clinical trials are also using abiraterone for earlier stages of prostate cancer and advanced breast cancer. Abiraterone is associated with a not uncommon rate of serum enzyme elevation during therapy, but has not been clearly linked to cases of clinically apparent liver injury with jaundice.
 
(2) Abiraterone is a steroidal compound with antiandrogen activity. it is a Cytochrome P450 17A1 Inhibitor. The mechanism of action of abiraterone is as a Cytochrome P450 17A1 Inhibitor, and Cytochrome P450 2D6 Inhibitor, and Cytochrome P450 2C8 Inhibitor that catalyzes the 17alpha-hydroxylation of steroid intermediates involved in testosterone synthesis. Administration of this agent may suppress testosterone production by both the testes and the adrenals to castrate-range levels.
 
Medical Usage for Active Pharmaceutical Ingredients Abiraterone:
 
(1) Abiraterone, a steroidal cytochrome P 450 17alpha-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent pr ostate cancer.
 
(2) Currently, for patients of advanced prostate cancer, androgen deprivation therapy including drugs and surgery is generally the preferred method of including drugs and surgery in order to reduce the testicular androgen synthesis. However, this treatment can't suppress other parts of the body for yielding the male hormone.
(3) Abiraterone is a therapeutic agent for prostate cancer with the English name for Abiraterone. It is developed by researchers coming from the British Royal Marsden Hospital located in southwest (world-renowned cancer research treatment center). It is kind of drug which is able to repress any part of the body for androgen production. It can not only reduce the levels of the prostate-specific antigen (PSA) which represents the tumor activity, but also helps to shrink the tumor. It can also apply to cancer patients who have been subject to chemotherapy in the past, revealing treatment hope.
 
Technical Testing Sheet of  Active Pharmaceutical Ingredients Abiraterone:
 
COA:
   
How to Complete an Order
 

Medical Equipment

We are Emergency Ambulance Equipment Manufacturers and Suppliers in China, the full name of AED is Automated External Defibrillator Medical Equipment(Emergency Ambulance Equipment). If a patient goes into cardiac arrest, we can defibrillate the heart with an AED shock, allowing the heart to return to its normal rhythm and out of danger. AED is an intelligent and convenient emergency equipment that can be used by ordinary people, which is used to rescue cardiac arrest caused by ventricular fibrillation and pulseless ventricular tachycardia. It discharges electricity to specific areas of the body and restores the heart to a normal heartbeat rhythm. The operation of the AED is very simple, and it can be used according to the voice prompts and screen animations of the instrument to determine whether the patient needs electric shock therapy. AED can be widely used in various public places, such as schools, shopping malls, railway stations, airports, subway stations, restaurants, etc. Many patients with cardiac arrest may suffer from hypoxia in a short period of time, and they have missed the most important time when the ambulance arrives. It is the best time for rescue, and AED and cardiopulmonary resuscitation can save time for the rescue of patients. When an emergency occurs and there is an AED on site, it can be used urgently to prolong the survival time of the rescued.

Medical Equipment,Medical Emergency Trolley Equipment,Emergency Ambulance Equipment,Medical Equipment Trolley

Haloxylon Ammodendron Medical Equipment Co., Ltd. , https://www1.haloxylonhospital.com